Iowa R.Ph.s stepping up to plate on Medicaid services
March 3rd 2003One half of the Iowa communnity pharmacists in 117 participating pharmacies in a Medicaid program failed to provide the pharmaceutical care services they were trained to offer and two thirds of eligible patients never received the services, according to a study.
First new treatment for rosacea in a decade to debut
February 17th 2003The FDA recently approved azelaic acid (Finacea, Berlex Laboratories) 15.0% gel for the topical treatment of the inflammatory papules and pustules characteristic of mild-to-moderate rosacea. Finacea should be available in pharmacies during the first quarter of 2003.
Massachusetts bashes R.Ph.s on Rx fee
February 3rd 2003The Massachusetts attorney general blasted pharmcies for passing a new $1.30 per Rx tax onto consumers. The tax was imposed to raise $36 million for the state Medicaid program but the law doesn't spell out whether pharmacies can charge consumers to the levy.
First human MAb offers RA patients effective option
January 20th 2003Patients with rheumatoid arthritis (RA) now have a first-of-its-kind therapeutic option that is safe, convenient, and effective. The FDA recently approved adalimumab (Humira, Abbott Laboratories) for reducing the signs and symptoms and inhibiting the progression of structural damage in adult patients with moderately to severely active RA who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs). The approval of adalimumab comes just nine months after regulatory submission. Adalimumab will be available in pharmacies by mid-January.
There's no simple route to compliance, study finds
January 20th 2003Keeping patients on long term therapy requires multifaceted interventions but even complex approaches don't lead to big improvements in adherence or improved outcomes, according to researchers from the McMaster University Faculty of Health Sciences in Ontario.